Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Nov 20, 2023
Open Peer Review Period: Nov 20, 2023 - Jan 15, 2024
Date Accepted: Jul 8, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Predictive Models for Long Term Survival of AML Patients Treated with Venetoclax and Azacitidine or 7+3 Based on Post Treatment Events and Responses: Retrospective Cohort Study

Islam N, Reuben JS, Dale J, Coates JW, Sapiah K, Markson FR, Jordan CT, Smith C

Predictive Models for Long Term Survival of AML Patients Treated with Venetoclax and Azacitidine or 7+3 Based on Post Treatment Events and Responses: Retrospective Cohort Study

JMIR Cancer 2024;10:e54740

DOI: 10.2196/54740

PMID: 39167784

PMCID: 11375398

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Per the author's request this version is not available.